Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis

In CRC, highly immunogenic neoantigens may be associated with tumor mutational burden and metastasis, whereas common neoantigens in primary and metastatic lesions may be immunologically suppressed.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-05-27
DOI
https://doi.org/10.21873/anticanres.17611
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis

KOJI TAMADA, Tatsuya Ioka, Ryouichi Tsunedomi, Yuki Nakagami et al.
Anticancer Research
Immunotherapy and Immune Responses
article

Immunogenicity of Neoantigens in Colorectal Cancer: Potential Influence of Tumor Mutation Burden, Stages, and Metastasis

KOJI TAMADA, Tatsuya Ioka, Ryouichi Tsunedomi, Yuki Nakagami, Hidenori Takahashi, Shoichi Hazama, Hiroaki Nagano, Shinobu Tomochika, Xiaowei Yu, Michihisa Iida
article en

Abstract

In CRC, highly immunogenic neoantigens may be associated with tumor mutational burden and metastasis, whereas common neoantigens in primary and metastatic lesions may be immunologically suppressed.

Anticancer ResearchVol. 45(6)
Yamaguchi University (JP), Yamaguchi University Hospital (JP)
Good health and well-being
Openalex Percentile: Top 87%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.